Global market access optimization

The most complete HTA & Pricing platform to optimize your decision making

Latest News

What is Evalumade?

Evalumade, global HTA database

A centralized information resource

Evalumade provides a unique and visual update of Health Technology Assessment decisions made by major institutions worldwide.

Precision, real-time tracking, easy-to-use formats make Evalumade the most innovative global HTA database, voted in by major pharmaceuticals companies and market access actors.

Immediate answer to key performance indicators

Dedicated to market access leaders, Evalumade offers clear top-level visual information about HTA decisions:

  • Responsive, graphical and interactive interface, ideal for touch screen devices.
  • Instinctive search by therapeutic area, HTA institution, date, status (published or in development), drug name and active ingredient.
  • Several filter levels for better access to information.
  • Built to facilitate extraction of charts and figures for use in presentations.

Discover Also


Prioritis is a global provider in market access solutions for pharmaceutical, biotechnology and medical devices. Prioritis undertakes support for pricing and reimbursement processes for new innovative drugs, extension of indications and reassessment of therapeutic areas.


Prismaccess platform contains a comprehensive, detailed record of HTA authorities’ decisions extracted into easy to navigate summaries.
It provides an integrated service to support decision making at all stage of the product’s life with detailed information on recommendations, clinical and economic limitations.

Stay Connected